Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA‐REG OUTCOME trial von Pellicori, Pierpaolo, Fitchett, David, Kosiborod, Mikhail N., Ofstad, Anne P., Seman, Leo, Zinman, Bernard, Zwiener, Isabella, Wanner, Christoph, George, Jyothis, Inzucchi, Silvio E., Testani, Jeffrey M., Cleland, John G.F.

Volltext

Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes--a cross-sectional study von Ulimoen, Geir Reinvik, Ofstad, Anne Pernille, Endresen, Knut, Gullestad, Lars, Johansen, Odd Erik, Borthne, Arne

Volltext

Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation von Arora, Satish, Ofstad, Anne P, Ulimoen, Geir R, Birkeland, Kåre I, Endresen, Knut, Gullestad, Lars, Johansen, Odd E

Volltext bestellen

Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality: Insights From the EMPA-REG OUTCOME Trial von Savarese, Gianluigi, Sattar, Naveed, Januzzi, James, Verma, Subodh, Lund, Lars H, Fitchett, David, Zeller, Cordula, George, Jyothis T, Brueckmann, Martina, Ofstad, Anne Pernille, Inzucchi, Silvio E, Wanner, Christoph, Zinman, Bernard, Butler, Javed

Volltext

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial von Anker, Stefan D, Butler, Javed, Filippatos, Gerasimos, Khan, Muhammad Shahzeb, Marx, Nikolaus, Lam, Carolyn SP, Schnaidt, Sven, Ofstad, Anne Pernille, Brueckmann, Martina, Jamal, Waheed, Bocchi, Edimar A, Ponikowski, Piotr, Perrone, Sergio V, Januzzi, James L, Verma, Subodh, Böhm, Michael, Ferreira, João Pedro, Pocock, Stuart J, Zannad, Faiez, Packer, Milton

Volltext